New drug patch passes first safety check in healthy volunteers
NCT ID NCT07167914
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tested a new drug called SFG-02 given through a skin patch in 32 healthy adults of Japanese and White backgrounds. The main goals were to check if the patch is safe and how the drug moves through the body. Since this was a Phase 1 trial in healthy people, it does not test whether the drug treats any disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- SFG-02 (transdermal patch)
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTH PARTICIPANTS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sumida Hospital
Tokyo, Japan